Research and Development

Showing 15 posts of 9615 posts found.

giorgio_bruno

Recipharm appoints general manager for Italian unit

April 30, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Giorgio Bruno, Recipharm

Contract development and manufacturing organisation Recipharm has confirmed that Dr Giorgio Bruno has been appointed general manager of Recipharm Italia. In …
GSK image

GSK shingles vaccine performs

April 29, 2015 Research and Development, Sales and Marketing GSK, GlaxoSmithKline, HZ/su, Merck, zostovax

GlaxoSmithKline’s HZ/su vaccine candidate for the prevention of shingles has demonstrated promising benefits across all age groups in a late-stage …
andreas_reimer_

RSA hires two consultants in Germany

April 29, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andreas Reimer, Ji Kwon, rsa

Executive search and interims firm RSA has appointed two consultants to its teams in the DACH region. Andreas Reimer (pictured) …
celgene-logo

Celgene splashes out on cancer R&D firm

April 28, 2015 Research and Development, Sales and Marketing

Oncology specialists Celgene have made a $485 million outlay to buy Quanticel Pharmaceuticals, to increase its effort and investment in …
The BioIndustry Association's Steve Bates

UK ‘has ten years to become global biotech leader’

April 28, 2015 Manufacturing and Production, Research and Development, Sales and Marketing

The UK should be home to ‘the third global cluster’ for biotech in the next 10 years, according to a …
gilenya__novartis_multiple_sclerosis

Researchers hit out at ‘alarming’ increase in MS drug costs

April 27, 2015 Manufacturing and Production, Research and Development, Sales and Marketing

Researchers have hit out at the ‘alarming’ rise in the costs of disease-modifying treatments for multiple sclerosis, in a new …
pillsphotos1

The Pharmafocus debate: Is the price of new hepatitis C treatments fair?

April 27, 2015 Research and Development, Sales and Marketing Doctors of the World, Drug pricing, EFPIA, Gilead, MSF, drug cost, hepatitis C, patents, sofosbuvir, sovaldi

YES – says Richard Bergström, director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), who argues that …
charlie-mayr_1

Actavis confirms retirement of its comms officer

April 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, charles mayr

Ireland-based pharma firm Actavis has announced its chief communications officer Charles Mayr (pictured) is to retire shortly due to health …
jeroen_tonnaer

Cristal Therapeutics hires chief business officer from Merck

April 23, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cristal Therapeutics, Jeroen Tonnaer, Merck

Jeroen Tonnaer has been named as the new chief business officer responsible for Cristal Therapeutics’ business development, partnering and licensing …
Pfizer image

Two oncology successes for Pfizer

April 22, 2015 Research and Development, Sales and Marketing Cancer, FDA, Inotuzumab ozogamicin, NSCLC, Pfizer, Xalkori, oncology

Pfizer has received two boosts in oncology as Xalkori gets a new breakthrough therapy designation from the FDA, and its …
goran_ando

EUSA Pharma appoints chief executive and director

April 22, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bryan Morton, Eusa Pharma, Göran Ando, Lee Morley

Recently-established UK-based EUSA Pharma has confirmed the appointment of Lee Morley as its chief executive and Dr Göran Ando (pictured) …
Teva image

Teva moves to buy Mylan

April 21, 2015 Research and Development, Sales and Marketing India, Mylan, Perrigo, Teva, US, Vigodman, generics, israel, merger

Israeli generics drug giant Teva has made an offer to buy its US rival Mylan for around $40.1 billion. The …
Pfizer image

Merck KGaA and Pfizer alliance begins lung cancer study

April 21, 2015 Research and Development, Sales and Marketing Merck KGaA, Pfizer, avelumab, keytruda, oncology, opdivo

Merck KGaA and Pfizer have enrolled and treated the first patient in a late-stage study of their anti-PD1 cancer immunotherapy …

Novartis MS drug scores positive late-stage trial result

April 21, 2015 Research and Development, Sales and Marketing MS, Novartis, fingolimod, gilenya, multiple sclerosis

People with some of the most common forms of multiple sclerosis (MS) who are treated with Gilenya are less likely …
vivian_huang

Four join the ranks of IDEA Pharma

April 21, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Anastasia Liapis, Cindy Peché, IDEA Pharma, Louise Ward, Vivian Huang

IDEA Pharma has made four new appointments in Louise Ward as project manager and Cindy Peché as head of group …
The Gateway to Local Adoption Series

Latest content